According to a new report Global Cough Syrup Market, published by KBV research, The Global Cough Syrup Market size is expected to reach $7.8 billion by 2026, rising at a market growth of 5.8% CAGR during the forecast period.
The Cough Suppressants market dominated the Global Cough Syrup Market by Product in 2019, growing at a CAGR of 4.2 % during the forecast period. The Combination Medications market is estimated to grow at a CAGR of 4.1% during (2020 - 2026). Additionally, The Expectorants market would experience highest CAGR of 5.2% during (2020 - 2026).
The Pediatric market dominated the Global Cough Syrup Market by Age Group in 2019, growing at a CAGR of 7 % during the forecast period. Additionally, The Adult market is expected to witness highest CAGR of 3.9% during (2020 - 2026).
The Asia Pacific market dominated the Global Cough Syrup Market by Region in 2019. The Europe market is experiencing a CAGR of 3.9% during (2020 - 2026). Additionally, The North America market is expected to witness a CAGR of 3% during (2020 - 2026). The LAMEA region is projected to witness the highest growth rate over the forecast years owing to the heavy investment of the governments in the development of healthcare infrastructure and growing cases of respiratory disorders.
Full Report: https://www.kbvresearch.com/cough-syrup-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Pfizer, Inc., Novartis AG, Merck Group, Johnson and Johnson, GlaxoSmithKline PLC (GSK), The Procter and Gamble Company, Reckitt Benckiser Group PLC, Abbott Laboratories, Sanofi S.A., and Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC).
By Product
By Age Group
By Distribution Channel
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
